Literature DB >> 7351142

Anergy in active pulmonary tuberculosis. A comparison between positive and negative reactors and an evaluation of 5 TU and 250 TU skin test doses.

D R Nash, J E Douglass.   

Abstract

Based on induration of less than 10 mm at 48 and 72 hours, 49 of 200 (25 percent) patients with active pulmonary tuberculosis failed to respond to intermediate (5TU) strength PPD. Distribution of reactors vs nonreactors was similar with regard to sex but not race, with more white subjects proving to be nonreactive. Additional comparisons between the two groups revealed significantly higher values in the responder population for age, in vitro lymphocyte response to PPD, total serum protein and serum IgG. Responsiveness of lymphocytes to phytohemagglutinin was also increased in this group, but only at lower mitogen concentrations. Alternatively, the nonresponder group demonstrated higher values for alpha-1 globulins. A group of nontuberculous patients similarly subjected to skin testing showed negative reactivity to 5 TU PPD at the much higher incidence of 152/173 (88 percent). The 49 patients with pulmonary tuberculosis and 152 nontuberculous patients who did not respond to 5 TU PPD were further tested with 250 TU PPD. In the group with tuberculosis, 30/49 (61.2 percent) demonstrated positive reactions, whereas only 55/152 (36.2 percent) nontuberculous patients showed induration equal to 10 mm or higher. Skin testing with the recall antigens TOE and SK-SD indicated that only 3/200 (1.5 percent) tuberculous patients could be classified as being anergic; 9/200 (4.5 percent) were specifically anergic to PPD and 7/200 (3.5 percent) demonstrated questionable anergy to PPD as judged by a 250 TU PPD response that was greater than 5 but less than 10 mm.

Entities:  

Mesh:

Year:  1980        PMID: 7351142     DOI: 10.1378/chest.77.1.32

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

1.  Unusual spinal tuberculosis after adequate chemotherapy for lymph node tuberculosis in an immunocompetent man.

Authors:  S P O'Hickey; A Pithie; C Skinner
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis.

Authors:  Y-M Lee; K-H Park; S-M Kim; S J Park; S-O Lee; S-H Choi; Y S Kim; J H Woo; S-H Kim
Journal:  Infection       Date:  2013-08-14       Impact factor: 3.553

3.  Tuberculin reactivity in tuberculous meningitis.

Authors:  B Mahadevan; S Mahadevan; V Tiroumourougane Serane; R Narasimhan
Journal:  Indian J Pediatr       Date:  2005-03       Impact factor: 1.967

Review 4.  Why intracellular parasitism need not be a degrading experience for Mycobacterium.

Authors:  D G Russell; S Sturgill-Koszycki; T Vanheyningen; H Collins; U E Schaible
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

5.  Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.

Authors:  K A Near; M J Lefford
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis.

Authors:  P D Johnson; R L Stuart; M L Grayson; D Olden; A Clancy; P Ravn; P Andersen; W J Britton; J S Rothel
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice.

Authors:  Sarah Gooding; Oni Chowdhury; Tim Hinks; Luca Richeldi; Monica Losi; Katie Ewer; Kerry Millington; Ruba Gunatheesan; Stefania Cerri; Jeremy McNally; Ajit Lalvani
Journal:  J Infect       Date:  2006-12-22       Impact factor: 6.072

10.  Tuberculous uveitis, a resurgent and underdiagnosed disease.

Authors:  Luca Cimino; Carl P Herbort; Raffaella Aldigeri; Carlo Salvarani; Luigi Boiardi
Journal:  Int Ophthalmol       Date:  2007-05-08       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.